Results 81 to 90 of about 21,757 (265)

Bacterial Vaccines and Serotype Replacement: Lessons from Haemophilus influenzae and Prospects for Streptococcus pneumoniae [PDF]

, 2016
Conjugate vaccines have reduced the incidence of invasive disease caused by Haemophilus influenzae, type b (Hib), in industrialized countries and may be highly effective against Streptococcus pneumoniae.
Lipsitch, Marc
core   +1 more source

Progress towards meningitis prevention in the conjugate vaccines era

Brazilian Journal of Infectious Diseases
Acute bacterial meningitis is an important cause of morbidity and mortality among children less than five years old. Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis are the most important agents of bacterial meningitis in ...
Cristina Aparecida Borges Laval, Fabiana Cristina Pimenta, João Guimarães de Andrade, Soraya S. Andrade, Ana Lucia S. S. de Andrade   +4 more
doaj   +1 more source

Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand

Frontiers in Public Health, 2017
Current study aimed to estimate clinical and economic outcomes of providing the Haemophilus influenzae type b (Hib) vaccination as a national vaccine immunization program in Thailand.
Surachai Kotirum, Surachai Kotirum, Charung Muangchana, Sirirat Techathawat, Piyameth Dilokthornsakul, David Bin-Chia Wu, Nathorn Chaiyakunapruk, Nathorn Chaiyakunapruk, Nathorn Chaiyakunapruk, Nathorn Chaiyakunapruk   +9 more
doaj   +1 more source

Membrane Protein As Novel Targets For Vaccine Production In Haemophilus Influenzae And Neisseria Meningitidis

, 2015
Haemophilus influenzae and Neisseria meningitis are gram negative, commensal bacteria naturally present in the nasopharynx. They are also naturally competent and suffer genetic mutations. H.
Izidoro Jr. M.S., de Hollanda L.M., Varela J.N., Lancellotti M.   +3 more
core   +1 more source

Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis

, 2002
The development of protein–polysaccharide conjugate vaccines has had a major impact on Haemophilus influenzae type b disease. The application of this technology to Neisseria meningitidis is also striking, particularly for serogroup C.
Kyd, Jennelle M., Foxwell, A. Ruth., Cripps, Allan W.   +2 more
core   +3 more sources

Evaluation of an alternative informed consent procedure for clinical trials conducted in The Gambia [PDF]

Background: Comprehension of informed consent poses greater challenges to clinical trial participants in The Gambia because of low literacy and absence of standardised formats for writing the local languages.
Afolabi, MO
core   +1 more source

Immunomodulation by microbial ribosomes

Memorias do Instituto Oswaldo Cruz, 1987
Over the past twenty years, many authors have reported evidence of the immunoprotective capacity of ribosomes isolated from bacteria, fungi and parasites.
W. Domzig, A. M. Pinel, G. Normier, L. Dussourd D'Hinterland   +3 more
doaj   +1 more source

A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE

Вопросы современной педиатрии, 2012
Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide.
Stanley A. Plotkin, Johannes Liese, Shabir A. Madhi, Esteban Ortiz   +3 more
doaj   +1 more source

Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. [PDF]

, 2011
BACKGROUND: Several decision support tools have been developed to aid policymaking regarding the adoption of pneumococcal conjugate vaccine (PCV) into national pediatric immunization programs.
A.M. Henao, Henao, Ana Maria, J. Hombach, Hutubessy, Raymond, Edmunds, John W, Beutels, Philippe, Joachim Hombach, Hutubessy Raymond, R. Somkrua, Chaiyakunapruk, Nathorn, Hombach, Joachim, R. Hutubessy, John W Edmunds, Ana Maria Henao, Philippe Beutels, Hombach Joachim, Nathorn Chaiyakunapruk, Henao Ana Maria, Edmunds John W, P. Beutels, Somkrua, Ratchadaporn, Edmunds, John W., Melegaro, Alessia, N. Chaiyakunapruk, Ratchadaporn Somkrua, Chaiyakunapruk Nathorn, Beutels Philippe, Raymond Hutubessy, Melegaro Alessia, Somkrua Ratchadaporn, Alessia Melegaro, W.J. Edmunds   +31 more
core   +1 more source

Safety and immunogenicity of an indigenously developedHaemophilus influenzaetype b conjugate vaccine through various phases of clinical trials [PDF]

, 2009
Hitt Sharma, Amrik S. Multani, A. K. Dutta, S M Joshi, Sushma Malik, Subodh Bhardwaj, Anita Chakravarty, Gajanan S. Namjoshi, Sameer Parekh, Vikas Verma   +9 more
openalex   +1 more source